A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds

It was much more accurate than primary care doctors using cognitive tests and CT scans. The findings could speed the quest for an affordable and accessible way to diagnose patients with memory problems.
New Drug Approved for Early Alzheimer’s

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.